Development and Characterization of a Nint-Loaded Nanoparticulate Matrix Tablet for Enhanced Solubility and Sustained Release
Keywords:
Nintedanib, Nanoparticles, Matrix Tablet, PLGA, Sustained Release, Bioavailability, Direct CompressionAbstract
Nintedanib, a tyrosine kinase inhibitor, is a critical treatment for idiopathic pulmonary fibrosis but suffers from poor aqueous solubility and low oral bioavailability of approximately 4.7% due to extensive first-pass metabolism. These limitations hinder its therapeutic efficacy and necessitate frequent dosing. To overcome these challenges, a novel nanoparticulate matrix tablet was developed. Nintedanib-loaded nanoparticles were formulated using the polymer PLGA via a solvent evaporation technique and were subsequently compressed into matrix tablets by direct compression using polymers like HPMC K4M and Microcrystalline Cellulose. The prepared nanoparticles were characterized for entrapment efficiency, morphology (SEM), and physical state (XRD). The matrix tablets underwent evaluation for pre- and post-compression parameters, I understand you'd like a downloadable Word file. However, as an AI, I cannot generate files for download
Downloads
References
Kour P, Bilandi A, Kataria MK, Swami H. Sustained release matrix tablets of miglitol: techniques implemented and patents. International Journal of Institutional Pharmacy and Life Sciences. 2015; 5(1):88-100.
Kara DD, Krishna VT, Pai GK. A Review on Manufacturing of Tablets by Using Various Granulation Technique. Journal of Global Pharma Technology. 2017;10(9):05-10.
Sharma M, Sharma R, Jain DK. Nanotechnology Based Approaches for Enhancing Oral Bioavailability of Poorly Water Soluble Antihypertensive Drugs. Scientifica. 2016; 2016:1-11.
Mehta A, Jain N, Grobler A, Vandana B. Role of Novel Drug Delivery Systems in Bioavailability Enhancement- At A Glance. International Journal of Drug Delivery Technology. 2016; 6(1): 7-26.
Koo OM, Rubinstein I, Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine: Nanotechnology, Biology and Medicine. 2005;1(3):193-212.
Bharali DJ, Khalil M, Gurbuz M, Simone TM, Mousa SA. Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers. International journal of nanomedicine. 2009;4:1-7.
Pathak Y, Thassu D, Deleers M. Pharmaceutical applications of nanoparticulate drug- delivery systems. Drugs and the pharmaceutical sciences. 2007;166:185.
Sitterberg J, Özcetin A, Ehrhardt C, Bakowsky U. Utilising atomic force microscopy for the characterisation of nanoscale drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics. 2010;74(1):2-13.
Gardikis K, Tsimplouli C, Dimas K, Micha-Screttas M, Demetzos C. New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers. International journal of pharmaceutics. 2010;402(1-2):231-237.
Bandawane A, Saudagar R. A Review on Novel Drug Delivery System: A Recent Trend.
Journal of Drug Delivery and Therapeutics. 2019;9(3):517-521.
Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced drug delivery reviews. 2003 Feb 24;55(3):329-47.
Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: therapeutic applications and developments. Clinical pharmacology & therapeutics. 2008;83(5):761-769.
Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. In Nanoscience And Technology: A Collection of Reviews from Nature Journals. 2010:239-250.
Saraf S. Applications of novel drug delivery system for herbal formulations. Fitoterapia. 2010;81(7):680-689.
Barenholz Y. Relevancy of drug loading to liposomal formulation therapeutic efficacy.
Journal of liposome research. 2003;13(1):1-8.
Chonn A, Cullis PR. Recent advances in liposomal drug-delivery systems. Current opinion in Biotechnology. 1995;6(6):698-708
Svenson S, Tomalia DA. Dendrimers as nanoparticulate drug carriers. In
Nanoparticulates as drug carriers. 2006 (p. 298). Imperial College Press London.
Muller RH, Keck CM. Challenges and solutions for the delivery of biotech drugs–a review of drug nanocrystal technology and lipid nanoparticles. Journal of biotechnology. 2004;113(1-3):151-170.
Kayser O, Lemke A, Hernandez-Trejo N. The impact of nanobiotechnology on the development of new drug delivery systems. Current pharmaceutical biotechnology. 2005;6(1):3-5.
Ochekpe NA, Olorunfemi PO, Ngwuluka NC. Nanotechnology and drug delivery part 2: nanostructures for drug delivery. Tropical Journal of Pharmaceutical Research. 2009;8(3):275-287.
Dingler A, Gohla S. Production of solid lipid nanoparticles (SLN): scaling up feasibilities. Journal of microencapsulation. 2002;19(1):11-16.
Lander R, Manger W, Scouloudis M, Ku A, Davis C, Lee A. Gaulin homogenization: a mechanistic study. Biotechnology progress. 2000;16(1):80-85.
Osada K, Christie RJ, Kataoka K. Polymeric micelles from poly (ethylene glycol)–poly (amino acid) block copolymer for drug and gene delivery. Journal of The Royal Society Interface. 2009 ;6(suppl_3):S325-339.
Trubetskoy OV, Finel M, Burke TJ, Trubetskoy VS. Evaluation of synthetic polymeric micelles as a stabilization medium for the handling of membrane proteins in pharmaceutical drug discovery. J Pharm Pharmaceut Sci. 2006;9(3):271-280.
Chen PC, Mwakwari SC, Oyelere AK. Gold nanoparticles: from nanomedicine to nanosensing. Nanotechnology, science and applications. 2008;1:45.
Omidfar K, Khorsand F, Azizi MD. New analytical applications of gold nanoparticles as label in antibody based sensors. Biosensors and Bioelectronics. 2013;43:336-347.
Firme III CP, Bandaru PR. Toxicity issues in the application of carbon nanotubes to biological systems. Nanomedicine: Nanotechnology, Biology and Medicine. 2010;6(2):245-256.
Elhissi A, Ahmed W, Hassan IU, Dhanak V, D'Emanuele A. Carbon nanotubes in cancer therapy and drug delivery. Journal of drug delivery. 2012;2012;1-10.
Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science. 2002;298(5599):1759-1762.
Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nature biotechnology. 2004;22(8):969.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
